Abstract
Many tumor suppressor genes (such as p16, Rb, VHL, E-cadherin, and hMLH1) that are silenced by mutation are also inactivated by gene silencing through DNA methylation. Characterization of genes hypermethylated in human cancers but not in normal tissues not only provides insights into cancer biology but also permits the use of methylation-specific polymerase chain reaction-based assays that could serve as diagnostic tests for the early detection and early diagnosis of this disease. To this end, research aimed at the identification and characterization of the methylation status of known and candidate tumor suppressor genes is one strategy for finding putative diagnostic markers. This chapter describes several methods of methylation analysis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bird, A. (1992) The essentials of DNA methylation. Cell 70, 5–8.
Bird, A. (1999) DNA methylation de novo. Science 286, 2287–2278.
Mohandas, T., Sparkes, R. S., and Shapiro, L. J. (1981) Reactivation of an inactive human X chromosome: Evidence for X inactivation by DNA methylation. Science 211, 393–396.
Okano, M., et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257.
Okano, M., Xie, S., and Li, E. (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19, 219–220.
Yoder, J. A., Walsh, C. P., and Bestor, T. H. (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13, 335–340.
Baylin, S. B., et al. (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141–196.
Herman, J. G., et al. (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826.
Herman, J. G., et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95, 6870–6875.
Rountree, M. R., et al. (2001) DNA methylation, chromatin inheritance, and cancer. Oncogene 20, 3156–3165.
Ueki, T., et al. (2000) Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 60, 1835–1839.
Gama-Sosa, M. A., et al. (1983) The 5-methylcytosine content of DNA from human tumors. Nucl. Acids Res. 11, 6883–6894.
Feinberg, A. P., et al. (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159–1161.
Piyathilake, C. J., et al. (2001) Altered global methylation of DNA: An epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum. Pathol. 32, 856–862.
Gitan, R. S., et al. (2002) Methylation-specific oligonucleotide microarray: A new potential for high-throughput methylation analysis. Genome Res. 12, 158–164.
Suzuki, H., et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31, 141–149.
Yamashita, K., et al. (2002) Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2, 485–495.
Sato, N., et al. (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 63, 3735–2742.
Costello, J. F., Plass, C., and Cavenee, W. K. (2002) Restriction landmark genome scanning. Methods Mol. Biol. 200, 53–70.
Costello, J. F., Smiraglia, D. J., and Plass, C. (2002) Restriction landmark genome scanning. Methods 27, 144–149.
Frommer, M., et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89, 1827–1831.
Reynaud, C., et al. (1992) Monitoring of urinary excretion of modified nucleo-sides in cancer patients using a set of six monoclonal antibodies. Cancer Lett. 61, 255–262.
Xiong, Z. and Laird, P. W. (1997) COBRA: A sensitive and quantitative DNA methy-lation assay. Nucl. Acids Res. 25, 2532–2534.
Gehrke, C. W., et al. (1984) Quantitative reversed-phase high-performance liquid chromatography of major and modified nucleosides in DNA. J. Chromatogr. 301, 199–219.
Lisitsyn, N. and Wigler, M. (1993) Cloning the differences between two complex genomes. Science 259, 946–951.
Schutte, M., et al. (1995) Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA 92, 5950–5954.
Grunau, C., Clark, S. J., and Rosenthal, A. (2001) Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucl. Acids Res. 29, E65–E65.
Baskaran, N., et al. (1996) Uniform amplification of a mixture of deoxyribonucleic acids with varying GC content. Genome Res. 6, 633–638.
Toyota, M., et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96, 8681–8686.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Curtis, C.D., Goggins, M. (2005). DNA Methylation Analysis in Human Cancer. In: Su, G.H. (eds) Pancreatic Cancer. Methods in Molecular Medicine™, vol 103. Humana Press. https://doi.org/10.1385/1-59259-780-7:123
Download citation
DOI: https://doi.org/10.1385/1-59259-780-7:123
Publisher Name: Humana Press
Print ISBN: 978-1-58829-107-3
Online ISBN: 978-1-59259-780-2
eBook Packages: Springer Protocols